breast milk eye drops

Breast milk eye drops are an investigational biologic therapy being studied for the prevention and treatment of retinopathy of prematurity (ROP) in preterm infants. Developed by researchers at Baskent University, this intervention involves the topical ophthalmic administration of the infant's own mother's breast milk. The therapeutic potential of breast milk in this context is attributed to its high concentration of pluripotent stem cells and various growth factors, which are hypothesized to differentiate into retinal cell layers and exert a regulatory influence on angiogenesis. By modulating the vascular development of the retina, the treatment aims to reduce the incidence and severity of ROP, a leading cause of blindness in premature newborns.

Other names

topical breast milkhuman breast milk eye drops